AbbVie Financials

Market Capitalization $336.94 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	81.52
Forward PE	15.73
Price to Sales TTM	$5.87
Price to Book MRQ	$237.25
Enterprise to Revenue	6.85
Enterprise to EBITDA	14.35

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	7.31%
Operating Margin	30.43%
Return on Assets TTM	8.34%
Return on Equity TTM	88.40%

Income Statement

Revenue TTM	$57,366,999,040
Revenue per Share TTM	$32.43
Quarterly Revenue Growth	8.40%
Gross Profit TTM	$40,739,000,320
EBITDA	$17,683,000,000
Net Income to Common TTM	$4,155,000,064
Diluted EPS TTM	$2.34
Quarterly Earnings Growth YoY	-6.10%

Balance Sheet

Total Cash MRQ	$5,176,000,000
Total Cash per Share MRQ	$2.93
Total Debt MRQ	$
Total Debt to Equity MRQ	4789.60
Current Ratio MRQ	0.76
Book Value per Share MRQ	$0.80

Cash Flow

Operating Cash Flow TTM	$16,401,000,448
Levered Free Cash Flow TTM	$16,941,375,488

ABBV Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,765,256,986
Float Shares	1,762,781,901
Avg 10 Volume	8,021,485
Avg 30 Volume	None
Shares Short	14,700,538
Short Ratio	2.50
Short % of Shares	0.83%
% Held by Insiders	0.10%
% Held by Institutions	74.40%

Stock Price Summary

Beta	0.49
Fifty Two Week Low	$163.63
Fifty Two Week High	$218.66
Fifty Two Week Change	11.64%
Day 50 MA	$186.83
Day 200 MA	$188.30

Dividends and Splits

Forward Annual Dividend Rate	$6.56
Forward Annual Dividend Yield	3.47%
Trailing Annual Dividend Rate	$6.38
Trailing Annual Dividend Yield	3.37%
Payout Ratio	268.80%
Dividend Date	2025-08-15
Ex Dividend Date	2025-07-15
Last Split Factor
Last Split Date